Floatz logo

ZIPRASIDONE

Schizophrenia and Schizoaffective Disorder

Solvay PharmaceuticalsSmall moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Schizophrenia and Schizoaffective Disorder cohort.

Asset / SponsorPhaseRating
Cipralex
Solvay Pharmaceuticals
Phase 3BB
CITALOPRAM
Solvay Pharmaceuticals
Phase 3BB
Sertraline
Solvay Pharmaceuticals
Phase 3BB
Seroquel®
Solvay Pharmaceuticals
Phase 3BB
Olanzapine
Solvay Pharmaceuticals
Phase 3BB
Risperdal
Solvay Pharmaceuticals
Phase 3BB

Same molecule, other indications

ZIPRASIDONE is also rated in:

schizoaffective disorderDormant
BBB
Indicative ·
76 / 100
View asset →
Depression, BipolarDormant
BBB
Indicative ·
73 / 100
View asset →
psychotic disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →